Capecitabine-based CRT showed a trend toward preferable progression free survival (PFS) in comparison to gemcitabine-based CRT after induction chemotherapy for LAPC [ 12 ].
← all excerpts
The Emerging Role of miRNAs for the Radiation Treatment of Pancreatic Cancer.
1
—
—